Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
Certara (NASDAQ: CERT) announced it will release its Q4 and full-year 2024 financial results after market close on February 26th, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (NASDAQ: CERT) announced it will release its Q4 and full-year 2024 financial results after market close on February 26th, 2025. Management will host a conference call at 5:00 PM ET to discuss the results, with advance registration required for investors.
Additionally, the company's management team will participate in two upcoming investor conferences in March: the Leerink Partners Global Healthcare Conference on March 11th at 1:00 PM ET and the Barclays 27th Annual Global Healthcare Conference on March 12th at 11:30 AM ET. Live and archived webcasts of these events will be available on Certara's investor relations website.
Details
News Market Reaction – CERT
The recorded move for CERT in the trading session of this news was +0.79%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
Certara also announced that company management will participate in the following investor conferences:
- Leerink Partners Global Healthcare Conference
Date and Time: Tuesday, March 11th at 1:00PM ET
- Barclays 27th Annual Global Healthcare Conference
Date and Time: Wednesday, March 12th at 11:30AM ET
Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.